DMKJ
BCRX icon

David M. Knott Jr’s BioCryst Pharmaceuticals BCRX Stock Holding History

David M. Knott Jr’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-32,570
Closed -$247K – 90
2025
Q3 		$247K Sell
32,570
-300,055
-90% -$2.5M 0.1% 60
2025
Q2 		$2.98M Sell
332,625
-127,375
-28% -$1.19M 1.35% 15
2025
Q1 		$3.45M Buy
460,000
+20,000
+5% +$161K 1.63% 13
2024
Q4 		$3.31M Buy
440,000
+58,000
+15% +$440K 1.2% 16
2024
Q3 		$2.9M Buy
382,000
+67,693
+22% +$515K 1.02% 21
2024
Q2 		$1.94M Buy
+314,307
New +$1.73M 0.77% 28

Other funds holding BCRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

David M. Knott Jr's BCRX Position: Q4 2025 in Review

David M. Knott Jr sold out of BioCryst Pharmaceuticals (BCRX) in Q4 2025, closing a stake of 32,570 shares — an estimated $247K sold.

David M. Knott Jr first reported a position in BCRX in Q2 2024 and held it in 6 quarters. The position peaked at $3.45M in Q1 2025. 272 funds tracked by Wall St. Rank hold BCRX as of Q4 2025.

  • David M. Knott Jr reported no remaining BioCryst Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • David M. Knott Jr sold 32,570 BioCryst Pharmaceuticals shares in Q4 2025, an estimated $247K.
  • David M. Knott Jr first reported a position in BioCryst Pharmaceuticals in Q2 2024 and held it in 6 quarters.
  • David M. Knott Jr's BioCryst Pharmaceuticals position peaked at $3.45M in Q1 2025.
  • 272 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q4 2025.

Based on David M. Knott Jr's 13F filing for Q4 2025, filed 12 Feb 2026.